File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1093/cid/ciz361
- Scopus: eid_2-s2.0-85076585306
- PMID: 31086993
- WOS: WOS:000506801100017
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Accelerated Immunodeficiency-associated Vaccine-derived Poliovirus Serotype 3 Sequence Evolution Rate in an 11-week-old Boy With X-linked Agammaglobulinemia and Perinatal Human Immunodeficiency Virus Exposure
Title | Accelerated Immunodeficiency-associated Vaccine-derived Poliovirus Serotype 3 Sequence Evolution Rate in an 11-week-old Boy With X-linked Agammaglobulinemia and Perinatal Human Immunodeficiency Virus Exposure |
---|---|
Authors | |
Keywords | oral poliovirus vaccine acute flaccid paralysis X-linked agammaglobulinemia Bruton tyrosine kinase HIV-exposed but uninfected |
Issue Date | 2020 |
Publisher | Oxford University Press. The Journal's web site is located at http://www.oxfordjournals.org/our_journals/cid/ |
Citation | Clinical Infectious Diseases, 2020, v. 70 n. 1, p. 132-135 How to Cite? |
Abstract | Primary B-cell immunodeficiencies are risk factors for the generation of vaccine-derived polioviruses. We report immunodeficiency-associated vaccine-derived poliovirus serotype 3 in an 11-week-old boy with X-linked agammaglobulinemia. Unique characteristics of this case include early age of presentation, high viral evolutionary rate, and the child’s perinatal exposure to human immunodeficiency virus. |
Persistent Identifier | http://hdl.handle.net/10722/294118 |
ISSN | 2023 Impact Factor: 8.2 2023 SCImago Journal Rankings: 3.308 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jallow, S | - |
dc.contributor.author | Wilmshurst, JM | - |
dc.contributor.author | Howard, W | - |
dc.contributor.author | Copelyn, J | - |
dc.contributor.author | Seakamela, L | - |
dc.contributor.author | Chan, KW | - |
dc.contributor.author | Sebunya, R | - |
dc.contributor.author | Sibiya, R | - |
dc.contributor.author | Du Plessis, H | - |
dc.contributor.author | Jacobs, C | - |
dc.contributor.author | Berkowitz, N | - |
dc.contributor.author | Blumberg, L | - |
dc.contributor.author | McCarthy, K | - |
dc.contributor.author | Maseti, E | - |
dc.contributor.author | Kamupira, M | - |
dc.contributor.author | Dlamini, N | - |
dc.contributor.author | Gumede, N | - |
dc.contributor.author | Diop, OM | - |
dc.contributor.author | Lau, YL | - |
dc.contributor.author | Moonsamy, S | - |
dc.contributor.author | Eley, B | - |
dc.contributor.author | Suchard, M | - |
dc.date.accessioned | 2020-11-23T08:26:35Z | - |
dc.date.available | 2020-11-23T08:26:35Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Clinical Infectious Diseases, 2020, v. 70 n. 1, p. 132-135 | - |
dc.identifier.issn | 1058-4838 | - |
dc.identifier.uri | http://hdl.handle.net/10722/294118 | - |
dc.description.abstract | Primary B-cell immunodeficiencies are risk factors for the generation of vaccine-derived polioviruses. We report immunodeficiency-associated vaccine-derived poliovirus serotype 3 in an 11-week-old boy with X-linked agammaglobulinemia. Unique characteristics of this case include early age of presentation, high viral evolutionary rate, and the child’s perinatal exposure to human immunodeficiency virus. | - |
dc.language | eng | - |
dc.publisher | Oxford University Press. The Journal's web site is located at http://www.oxfordjournals.org/our_journals/cid/ | - |
dc.relation.ispartof | Clinical Infectious Diseases | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | oral poliovirus vaccine | - |
dc.subject | acute flaccid paralysis | - |
dc.subject | X-linked agammaglobulinemia | - |
dc.subject | Bruton tyrosine kinase | - |
dc.subject | HIV-exposed but uninfected | - |
dc.title | Accelerated Immunodeficiency-associated Vaccine-derived Poliovirus Serotype 3 Sequence Evolution Rate in an 11-week-old Boy With X-linked Agammaglobulinemia and Perinatal Human Immunodeficiency Virus Exposure | - |
dc.type | Article | - |
dc.identifier.email | Chan, KW: kwchan@hku.hk | - |
dc.identifier.email | Lau, YL: lauylung@hku.hk | - |
dc.identifier.authority | Lau, YL=rp00361 | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.1093/cid/ciz361 | - |
dc.identifier.pmid | 31086993 | - |
dc.identifier.pmcid | PMC6912151 | - |
dc.identifier.scopus | eid_2-s2.0-85076585306 | - |
dc.identifier.hkuros | 318982 | - |
dc.identifier.volume | 70 | - |
dc.identifier.issue | 1 | - |
dc.identifier.spage | 132 | - |
dc.identifier.epage | 135 | - |
dc.identifier.isi | WOS:000506801100017 | - |
dc.publisher.place | United States | - |
dc.identifier.issnl | 1058-4838 | - |